SCHEMBL1758844

SCHEMBL1758844

[CH]c1ncccc1OCCF

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.37
MAPT P10636 4/20 0.37
KDM4E B2RXH2 3/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
SLC18A3 Q16572 1/20 0.35
NPC1 O15118 3/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RECQL P46063 1/20 0.35
GAA P10253 2/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
S1PR4 O95977 1/20 0.34
CYP11B1 P15538 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9980697 0.77 S1PR4 (0.55) RAB9AMAPTKDM4ELMNASMN1; SMN2
SCHEMBL12031808 0.77 CHRNB2 (0.46) RAB9AMAPTKDM4ELMNASMN1; SMN2
SCHEMBL1759055 0.74 ALDH1A1 (0.48) RAB9AMAPTKDM4ELMNASMN1; SMN2
SCHEMBL2936738 0.74 KDM4E (0.61) RAB9AMAPTKDM4ELMNASMN1; SMN2
SCHEMBL15489133 0.70 SLC18A3 (0.46) MAPTKDM4ELMNASMN1; SMN2SLC18A3
SCHEMBL8536024 0.70 S1PR1 (0.38) RAB9AKDM4ELMNASMN1; SMN2SLC18A3
SCHEMBL10458360 0.69 HTR1B (0.53) MAPTKDM4E
SCHEMBL10458074 0.69 LMNA (0.52) RAB9AMAPTKDM4ELMNASMN1; SMN2
SCHEMBL10750620 0.68 MEN1 (0.32) MEN1KMT2A
SCHEMBL22111020 0.67 L3MBTL1 (0.60) RAB9AMAPTKDM4ELMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493513-A1 RADIOLABELLED PDE10 LIGANDS Janssen Pharmaceutica, N.V. (BE) 2012-09-05 EP disclosed
WO-2011051324-A1 RADIOLABELLED PDE10 LIGANDS JANSSEN PHARMACEUTICA NV (BE) 2011-05-05 WO disclosed